A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

Name: A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
Published: 2012
License: Public Domain

GlaxoSmithKline · 2012

ClinicalTrials.gov · Datasets · License: Public Domain · 2012

Open Source ↗

celltherapy immuno neoplasms ny oncology

neoplasms, t cell receptor, sarcoma, cell therapy, t cell therapy, previously treated, ny-eso-1, metastatic, immuno-oncology, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma

Related documents